Dokumendiregister | Ravimiamet |
Viit | REP-1/3446-2 |
Registreeritud | 25.09.2024 |
Sünkroonitud | 26.09.2024 |
Liik | Väljaminev kiri |
Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
Toimik | REP-1/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | European Directorate for the Quality of Medicines & HealthCare |
Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
Vastutaja | Signe Leito (RA, Labor) |
Originaal | Ava uues aknas |
Survey for information on approved products containing anhydrous ephedrine, ephedrine hemihydrate or ephedrine hydrochloride, racemic
page 1 / 5
Q1-3 (3566)
NPA: (47330) Type: (!/list-dropdown)
A10 - Estonia (EE)
Is Ephedrine (0488, anhydrous base) used in approved products in your country?
(47331) Type: (L/list-radio)
No
A3
page 2 / 5
Please list the names of any approved products in your country containing Ephedrine (0488)
and the contact details of any corresponding MAH(s) or information on substance
manufacturers. (47332) Type: (T/text-long)
n.a
Is Ephedrine hemihydrate (0489) used in approved products in your country? (47336) Type: (L/list-radio)
No
AO03
Please list the names of any approved products in your country containing Ephedrine
hemihydrate (0489) and the contact details of any corresponding MAH(s) or information on
substance manufacturers.
(47333) Type: (T/text-long)
n.a
page 3 / 5
Is racemic Ephedrine hydrochloride (0715, anhydrous) used in approved products in your
country? (47337) Type: (L/list-radio)
No
AO02
Please list the names of any approved products in your country containing Ephedrine
hydrochloride, racemic (0715) and the contact details of any corresponding MAH(s) or
information on substance manufacturers.
(47334) Type: (T/text-long)
n.a
Comments:
(47335) Type: (T/text-long)
-
page 4 / 5
Powered by TCPDF (www.tcpdf.org)
page 5 / 5
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Euroopa farmakopöa töökava asjus | 25.09.2024 | 1 | REP-1/3446-1 | Sissetulev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |